electroCore announces NIDA awarded Emory University, Georgia Institute a grant

electroCore announced that the National Institute on Drug Abuse, NIDA, part of the National Institutes of Health, NIH, has awarded Emory University and the Georgia Institute of Technology a 3-year, $6.0 million grant through the NIH Helping to End Addiction Long Term, HEAL, Initiative to conduct a pivotal clinical trial of gammaCore, NVNS, for the treatment of opioid use disorder, OUD. The double-blind, randomized, sham-controlled study is based on the successful completion and publication of a pilot study that showed that gammaCore nVNS reduced both the psychological and physiological symptoms of acute opioid withdrawal.6 The study to be funded by the grant will recruit approximately 100 patients with OUD. The primary efficacy endpoint of this study will be peak difference in the Subjective Opioid Withdrawal Score between nVNS and sham treatment on day 2 and 3 of the initial withdrawal period.